On September 11, 2026, a clinical trial update was recorded for a study involving glucagon. The trial, titled "Nutrition for Precision Health, Powered by the All of Us," is listed under identifier NCT05701657. Its current status is recruiting. The trial phase is listed as not applicable. No results have been posted for this study as of this update. The update does not describe study outcomes, efficacy, or safety findings. It reflects only the current recruitment status and phase classification of the trial as recorded on the specified date. Readers interested in the specific design, eligibility criteria, or sponsor details of this trial can consult the official listing directly. This brief reports only the status change and does not represent an interpretation of trial results or clinical significance. Glucagon remains an approved compound, and this trial update does not alter its regulatory status. For general background on glucagon, including its approved uses and mechanism, readers can consult the compound overview.
Glucagon Study Update: "Nutrition for Precision Health" Trial Recruiting
See the full glucagon overview
Source: https://clinicaltrials.gov/study/NCT05701657